Abbate, Antonio

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 658

Exercise Intolerance in Patients With Heart Failure

Del Buono, M. G., Arena, R., Borlaug, B. A., Carbone, S., Canada, J. M., Kirkman, D. L., Garten, R., Rodriguez-Miguelez, P., Guazzi, M., Lavie, C. J., et al. (2019) · Journal of the American College of Cardiology

Cardiovascular and exercise physiologyHeart Failure Treatment and Management

Cited by 477

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial

Spertus, J. A., Birmingham, M. C., Nassif, M., Damaraju, C. V., Abbate, A., Butler, J., Lanfear, D. E., Lingvay, I., Kosiborod, M. N., & Januzzi, J. L. (2022) · Nature Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 245

Acute Myocarditis Associated With Desmosomal Gene Variants

Ammirati, E., Raimondi, F., Piriou, N., Sardo Infirri, L., Mohiddin, S. A., Mazzanti, A., Shenoy, C., Cavallari, U. A., Imazio, M., Aquaro, G. D., et al. (2022) · JACC: Heart Failure

Viral Infections and Immunology ResearchCardiomyopathy and Myosin Studies

Cited by 150

Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study

Biondi-Zoccai, G. G. L., Lotrionte, M., Abbate, A., Testa, L., Remigi, E., Burzotta, F., Valgimigli, M., Romagnoli, E., Crea, F., & Agostoni, P. (2006) · BMJ

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 149

Inflammasome formation in the lungs of patients with fatal COVID-19

Toldo, S., Bussani, R., Nuzzi, V., Bonaventura, A., Mauro, A. G., Cannatà, A., Pillappa, R., Sinagra, G., Nana-Sinkam, P., Sime, P., et al. (2021) · Inflammation Research

Inflammasome and immune disordersCOVID-19 Clinical Research Studies

Cited by 132

Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials

Lombardi, M., Carbone, S., Del Buono, M. G., Chiabrando, J. G., Vescovo, G. M., Camilli, M., Montone, R. A., Vergallo, R., Abbate, A., Biondi-Zoccai, G., et al. (2021) · European Heart Journal - Cardiovascular Pharmacotherapy

Fatty Acid Research and HealthAtrial Fibrillation Management and Outcomes

Cited by 68

A review of PCSK9 inhibition and its effects beyond LDL receptors

Dixon, D. L., Trankle, C., Buckley, L., Parod, E., Carbone, S., Van Tassell, B. W., & Abbate, A. (2016) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 53

Sarcopenic obesity is associated with reduced cardiorespiratory fitness compared with nonsarcopenic obesity in patients with heart failure with reduced ejection fraction

Billingsley, H. E., Del Buono, M. G., Canada, J. M., Kim, Y., Damonte, J. I., Trankle, C. R., Halasz, G., Mihalick, V., Vecchié, A., Markley, R. R., et al. (2022) · Circulation: Heart Failure

Cardiovascular and exercise physiologyNutrition and Health in Aging

Cited by 52

No-reflow: The next challenge in treatment of ST-elevation acute myocardial infarction

Abbate, A., Kontos, M. C., & Biondi-Zoccai, G. G. L. (2008) · European Heart Journal

Acute Myocardial Infarction ResearchCardiac Ischemia and Reperfusion

Cited by 50

Impact of Different Doses of Omega-3 Fatty Acids on Cardiovascular Outcomes: a Pairwise and Network Meta-analysis

Lombardi, M., Chiabrando, J. G., Vescovo, G. M., Bressi, E., Del Buono, M. G., Carbone, S., Koenig, R. A., Van Tassell, B. W., Abbate, A., Biondi-Zoccai, G., et al. (2020) · Current Atherosclerosis Reports

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 33

Evidence-Based Psychotherapy in Ischemic Heart Disease: Umbrella Review and Updated Meta-Analysis

Biondi-Zoccai, G., Mazza, M., Roever, L., van Dixhoorn, J., Frati, G., & Abbate, A. (2016) · Psychotherapy for Ischemic Heart Disease

Cardiac Health and Mental HealthPsychotherapy Techniques and Applications

Cited by 9

Pulmonary arterial hypertension and the Enigma code of smouldering inflammation

Gomez-Arroyo, J., Abbate, A., & Voelkel, N. F. (2016) · European Respiratory Journal

Pulmonary Hypertension Research and TreatmentsTransplantation: Methods and Outcomes

Cited by 8

Heart Rate Lowering With Ivabradine and Burden of Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome

Marchetta, M., Lopez, R. I., Hogwood, A. C., Thomas, G., Abbate, G., Markley, R., Canada, J. M., & Abbate, A. (2025) · Journal of Cardiovascular Pharmacology

Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic Control

Cited by 6